BN Business News
Add your company to Business Communicator →

International trade · 05/01/2023Updated: 10/17/2026 · 1 min read

U.S. International Trade Commission Seeks Comments on Thyroid Hormone Receptor-Beta Agonists Complaint

Summary

The U.S. International Trade Commission has received a complaint regarding Certain Selective Thyroid Hormone Receptor-Beta Agonists, Processes for Manufacturing or Relating to Same, and Products Containing Same, DN 3662, and is now soliciting public comments on any public interest issues raised by the complaint or the complainant's filing.

Original source language: Federal Register — International Trade CommissionOpen original release →

Explore insights

Business insights →